Alzheimer Drug Plus SSRI May Improve Depression/Cognition

By |2019-03-06T13:40:42-08:00March 6th, 2019|Brief Bulletins from the Field, Uncategorized, We Know Psychiatry|

Adding the Alzheimer drug memantine (Namenda, Allergan) to treatment with a selective serotonin reuptake inhibitor may improve depressive symptoms, executive function, and other outcomes in older patients with both depression and cognitive complaints, new research suggests. The findings were presented at the American Association of Geriatric Psychiatry (AAGP) 2019. In a [...]

Smoking Cessation Drug May Boost Cognition in Schizophrenia

By |2021-11-11T17:14:20-08:00March 22nd, 2017|Brief Bulletins from the Field, We Know Psychiatry|

In findings reported in a letter to the editor published online March 10 in Schizophrenia Research and reported by Medscape Medical News, the smoking cessation drug varenicline (Chantix) appears to enhance cognition in nonsmoking individuals with and those without schizophrenia. The results also showed that the drug reduced the cognitive [...]

Title

Go to Top